Banner for leaf pages 2

Irbesartan (Avapro)

Also known as Avapro

Irbesartan (INN) is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. Irbesartan was developed by Sanofi Research (now part of sanofi-aventis). It is jointly marketed by sanofi-aventis and Bristol-Myers Squibb under the trade names Aprovel, Karvea, and Avapro.

Source: Wikipedia

DEA Class 4 meaning a low potential for abuse and low risk of dependence.

Estimated Total Cost: $72.65 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed irbesartan to treat anemia due to chronic kidney disease, polycystic kidney disease, bladder obstruction, and polycythemia vera.

What drug interactions are known?

Do not take irbesartan if you are taking any of the following:

Critical Interactions

Significant Interactions

Ajax-loader Loading...